Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-03-21
1978-11-28
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31165
Patent
active
041276744
ABSTRACT:
An ophthalmic composition comprising a compound having the structural formula ##STR1## wherein X is selected from the group consisting of CH.sub.2 --CH.sub.2, CH.sub.2 and OCH.sub.2 ; and Y is selected from the group consisting of phenyl, P-methoxy phenyl and O-methoxy phenyl and a pharmaceutically acceptable salt thereof and a topically administrable ophthalmic pharmaceutical carrier. The foregoing composition is useful in lowering intraocular pressure in the eye. Reduction of intraocular pressure is of particular importance in the treatment of glaucoma, a disease characterized by elevated intraocular pressure.
REFERENCES:
patent: 3644353 (1972-02-01), Lunts et al.
patent: 3644520 (1972-02-01), Hartley et al.
patent: 3705233 (1972-12-01), Lunts et al.
patent: 3732300 (1973-05-01), Lunts et al.
patent: 3818101 (1974-06-01), Baile et al.
patent: 3944611 (1976-03-01), Smith
patent: 4012444 (1977-03-01), Lunts et al.
Chem. Abst. 71, 91066(f), (1969) - Lunts et al.
Chem. Abst. 77, 147,680(v), (1972) - Farmer et al.
Chem. Abst. 84, 38912(w), (1976) - Richards et al.
Allergan Pharmaceuticals, Inc.
Meyers Albert T.
Robinson D. W.
Voet Martin A.
LandOfFree
Method of treatment for glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment for glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-978217